Oseltamivir phos 75 MG capsule UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ2VE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,162
Award facts
- Contract value 100% obligated
- $4,162.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,162.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract, which carried no set-aside designation, was fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The parent organization, Cencora, Inc., holds the primary $999,999,999.00 IDC with DLA Troop Support Medical through December 2031, enabling both the parent and subsidiary to efficiently fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FZ2VE?
SPE2DR26FZ2VE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FZ2VE worth?
The government has obligated $4,162 on SPE2DR26FZ2VE.
Is contract SPE2DR26FZ2VE an order under another contract?
Yes. SPE2DR26FZ2VE is a delivery order under SPE2DR25D1120, an indefinite delivery contract.
Was contract SPE2DR26FZ2VE competed?
The extent of competition for SPE2DR26FZ2VE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award